ARCHIVES

Memphis CCOP Withdrawn, Says Lack Of Patient Benefits, Excess Tests Discouraged Local Physicians

This article is from The Cancer Letter archive.

Vol. 10 No. 44 | November 16, 1984

Download PDF Visit The Full Archive

Related Articles

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Complete List of Recommendations by Centers Committee

October 18, 1996

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

In Brief: Dmitrovsky Named Provost at MD Anderson; Paulsen Leaves To Chair Duke Radiology

April 12, 2013

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997